Fannie Huang

3.0k total citations · 3 hit papers
14 papers, 2.3k citations indexed

About

Fannie Huang is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Fannie Huang has authored 14 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Molecular Biology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Fannie Huang's work include Ion channel regulation and function (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Lipoproteins and Cardiovascular Health (5 papers). Fannie Huang is often cited by papers focused on Ion channel regulation and function (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Lipoproteins and Cardiovascular Health (5 papers). Fannie Huang collaborates with scholars based in United States, Italy and Norway. Fannie Huang's co-authors include Andrew R. Marks, Steven Reiken, Scott M. Wasserman, Nora Rosemblit, Robert P. Giugliano, Robert C. Scott, Marc S. Sabatine, Stephan E. Lehnart, Xander H.T. Wehrens and Payal Kohli and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Fannie Huang

14 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death

2003 561 citations Xander H.T. Wehrens, Stephan E. Lehnart et al. Cell profile →
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

2012 354 citations Robert P. Giugliano, Nihar R. Desai et al. The Lancet profile →
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

2014 281 citations Frederick J. Raal, Robert P. Giugliano et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Fannie Huang

Since Specialization

Citations

This map shows the geographic impact of Fannie Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fannie Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fannie Huang more than expected).

Fields of papers citing papers by Fannie Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fannie Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fannie Huang. The network helps show where Fannie Huang may publish in the future.

Co-authorship network of co-authors of Fannie Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Fannie Huang. A scholar is included among the top collaborators of Fannie Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fannie Huang. Fannie Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Smartphone-delivered, therapist-supported digital health intervention for physicians with burnout 2019 ·PsyArXiv (OSF Preprints) ·Valerie L. Forman‐Hoffman, Anu Raevuori, Philippe R. Goldin, (unknown), Susan Connolly, Ellis C. Dillon, (unknown), (unknown), (unknown), (unknown), Fannie Huang	3
2	Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145) breakdown → 2014 ·Journal of the American College of Cardiology ·Frederick J. Raal, Robert P. Giugliano, Marc S. Sabatine, Michael J. Koren, Gisle Langslet, Harold Bays, Dirk Blom, Mats Eriksson, Ricardo Dent, Scott M. Wasserman, Fannie Huang, Allen Xue, Moetaz Albizem, Robert C. Scott, Evan A. Stein	281
3	Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk 2014 ·Circulation Journal ·Atsushi Hirayama, Narimon Honarpour, Masayuki Yoshida, Shizuya Yamashita, Fannie Huang, Scott M. Wasserman, Tamio Teramoto	96
4	AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy 2013 ·Circulation ·Nihar R. Desai, Payal Kohli, Robert P. Giugliano, Michelle L. O’Donoghue, Ransi Somaratne, Jing Zhou, Elaine Hoffman, Fannie Huang, William J. Rogers, Scott M. Wasserman, Robert C. Scott, Marc S. Sabatine	152
5	Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study breakdown → 2012 ·The Lancet ·Robert P. Giugliano, Nihar R. Desai, Payal Kohli, William J. Rogers, Ransi Somaratne, Fannie Huang, (unknown), Satishkumar Mohanavelu, Elaine Hoffman, (unknown), (unknown), Scott M. Wasserman, Robert C. Scott, Marc S. Sabatine	354
6	Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy 2012 ·Clinical Cardiology ·Payal Kohli, Nihar R. Desai, Robert P. Giugliano, Jae Bum Kim, Ransi Somaratne, Fannie Huang, Beat Knüsel, (unknown), (unknown), Scott M. Wasserman, Robert C. Scott, Marc S. Sabatine	38
7	Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes 2010 ·New England Journal of Medicine ·Scott D. Solomon, Hajime Uno, Eldrin F. Lewis, Kai‐Uwe Eckardt, Julie Lin, Emmanuel A. Burdmann, Dick de Zeeuw, Peter Ivanovich, Andrew S. Levey, Patrick S. Parfrey, Giuseppe Remuzzi, Ajay Singh, Robert D. Toto, Fannie Huang, Jérôme Rossert, John J.V. McMurray, Marc A. Pfeffer	337
8	Empirical Methods to Calculate an Erythropoiesis-Stimulating Agent Dose Conversion Ratio in Nondialyzed Patients with Chronic Kidney Disease 2009 ·Journal of Managed Care Pharmacy ·Jeffrey C. Horowitz, Anil Agarwal, Fannie Huang, (unknown), Shravanthi R. Gandra, (unknown)	14
9	Analysis of calstabin2 (FKBP12.6)–ryanodine receptor interactions: Rescue of heart failure by calstabin2 in mice 2006 ·Proceedings of the National Academy of Sciences ·Fannie Huang, Jian Shan, Steven Reiken, Xander H.T. Wehrens, Andrew R. Marks	70
10	FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death breakdown → 2003 ·Cell ·Xander H.T. Wehrens, Stephan E. Lehnart, Fannie Huang, Joshua R. Vest, Steven Reiken, Peter J. Mohler, Jie Sun, Sílvia Guatimosim, Long‐Sheng Song, Nora Rosemblit, Jeanine D’Armiento, Carlo Napolitano, Mirella Memmi, Silvia G. Priori, W. Jonathan Lederer, Andrew R. Marks	561
11	Immunophilins and Coupled Gating of Ryanodine Receptors 2003 ·Current Topics in Medicinal Chemistry ·Stephan E. Lehnart, Fannie Huang, Steven O. Marx, Andrew R. Marks	40
12	PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle 2003 ·The Journal of Cell Biology ·Steven Reiken, Alain Lacampagne, Hua Zhou, Aftab R. Kherani, Stephan E. Lehnart, Christopher W. Ward, Fannie Huang, Marta Gaburjáková, Jana Gaburjáková, Nora Rosemblit, (unknown), Kunlun He, Geng‐Hua Yi, Jie Wang, Daniel Burkhoff, Guy Vassort, Andrew R. Marks	198
13	FKBP12 Binding Modulates Ryanodine Receptor Channel Gating 2001 ·Journal of Biological Chemistry ·Marta Gaburjáková, Jana Gaburjáková, Steven Reiken, Fannie Huang, Steven O. Marx, Nora Rosemblit, Andrew R. Marks	137
14	Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection 1998 ·Journal of Virology ·Colby A. Wyatt, Linda Andrus, Betsy Brotman, Fannie Huang, Dong‐Hun Lee, Alfred M. Prince	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact